Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Aprepitant 125mg capsules |
| BNF code | 0406000ADAAABAB |
| Virtual Therapeutic Moiety | Aprepitant |
| Date identifier became valid | 7 Jul 2023 |
| Previous product identifier | 409209003 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 6 Jan 2005 |
| Previous name | Aprepitant 125mg capsules |
| Basis of previous name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Aprepitant |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 125.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Aprepitant 125mg capsules (A A H Pharmaceuticals Ltd) | |
| Aprepitant 125mg capsules (Accord-UK Ltd) | |
| Aprepitant 125mg capsules (Martindale Pharmaceuticals Ltd) | |
| Aprepitant 125mg capsules (Sandoz Ltd) | |
| Aprepitant 125mg capsules (Viatris UK Healthcare Ltd) | |
| Aprepitant 125mg capsules (Zentiva Pharma UK Ltd) | |
| Emend 125mg capsules (Merck Sharp & Dohme (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Aprepitant 125mg capsules 1 capsule | |
| Aprepitant 125mg capsules 5 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.